Basic Information
GAIA BioMedicine, Inc., founded in 2015 by Professor Yoshikazu Yonemitsu (Kyushu University Graduate School), is a spin-off company from Kyushu University. Currently, as a clinical-stage, technology-driven biopharmaceutical company, Gaia is advancing a solid cancer cell therapy program based on Gaia-102 (NK-like cells).
GAIA BioMedicine, Inc.
Fukuoka,Fukuoka,Japan
unclear
October 01, 2015
info@gaia-biomed.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios